Every 8-K that DIH HOLDINGS US INC A (DHAI) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow DHAI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full DHAI filings page.
DIH Holding US, Inc. disclosed that Jason Chen, its former Chief Executive Officer, has also resigned from the company’s Board of Directors. The filing explains that Mr. Chen had previously notified the Board on November 24, 2025 that he was resigning as Chief Executive Officer and on November 25, 2025 that he was resigning from similar positions at all subsidiaries. On December 15, 2025, he further notified the Board that he was resigning as a director of the company, including all committee memberships, with his resignation effective upon notice.
DIH Holding US, Inc. reported a major leadership change. On November 24, 2025, Chief Executive Officer Jason Chen notified the Board that he was resigning as CEO of the company, effective immediately. On November 25, 2025, he also resigned from all similar positions at the company’s subsidiaries.
Although Jason Chen has stepped down from his executive roles, he will remain a member of the Board of Directors, so he will still be involved in overseeing the company at the board level. The Board has not yet appointed a replacement CEO, leaving a temporary gap in day-to-day executive leadership while a successor is identified.
DIH Holding US, Inc. (DHAI) announced its Nasdaq delisting. A Nasdaq Hearings Panel denied the company’s request to remain listed, and trading in its securities will be suspended at the open on November 7, 2025. The company’s Class A common stock and warrants had traded on Nasdaq under DHAI and DHAIW.
The company does not intend to seek further review of the decision. It plans to have its securities quoted over the counter under the same symbols, but warns there may be a very limited market and that shareholders may find it difficult to sell shares, with trading prices potentially adversely affected.
Management and auditors had previously noted substantial doubt about the company’s ability to continue as a going concern. Following the delisting decision, the company concluded additional capital needed for day-to-day operations will be unavailable and has suspended operations while evaluating strategic alternatives.
DIH Holding US, Inc. entered a common shares purchase agreement with an investor, enabling sales of up to the lesser of $22,000,000 in aggregate gross purchase price or 10,458,031 Class A common shares in a private placement. Purchases will be priced at 94% of the lowest daily VWAP over the prior three trading days including the purchase date.
As a commitment fee, the investor received 100,000 shares and a pre-funded warrant for 100,000 shares, which are to be returned if the Company’s Nasdaq Hearings Panel Appeal is not successful. DIH plans to use net proceeds for working capital and general purposes and will file a resale registration statement within 45 trading days. The agreement terminates on the first day of the month following the 36‑month anniversary of the initial registration statement’s effective date.
DIH Holding US, Inc. (DHAI) furnished an 8-K announcing its fourth quarter and fiscal year ended March 31, 2025 financial results. The company issued a press release on October 20, 2025, which is included as Exhibit 99.1.
The filing is informational, pointing investors to the press release for details. DIH Holding’s Class A Common Stock (DHAI) and Warrants (DHAIW) are listed on The Nasdaq Stock Market LLC.
DIH Holding US, Inc. (DHAI) enacted a one-for-twenty-five reverse stock split of its Class A common stock, effective at 5:00 p.m. Eastern Time on October 17, 2025. The shares will begin trading on the Nasdaq Capital Market on a split-adjusted basis on October 20, 2025.
The reverse split does not change the total number of authorized shares. No fractional shares were issued; holders otherwise entitled to a fraction will receive one whole share. Outstanding options and warrants were adjusted proportionately. Continental Stock Transfer & Trust Company is serving as exchange agent.
DIH Holding US, Inc. reports that Nasdaq is now considering multiple listing deficiencies that could lead to delisting of its Class A common stock and warrants. The company failed to regain compliance with Nasdaq’s market value of publicly held shares rule, which requires at least $15,000,000, within the 180‑day grace period ending October 1, 2025. This comes on top of earlier notices tied to its market value of listed securities falling below $50,000,000 and its share price staying under $1.00 for 30 consecutive business days.
On October 7, 2025, Nasdaq’s Hearings Panel informed the company it will factor this new deficiency into its decision on continued listing. DIH has requested a hearing and a stay of suspension while it presents a plan to regain compliance with all rules, including overdue Form 10‑Q and Form 10‑K reports. The Panel may grant time extensions, but there is no assurance DIH will maintain its Nasdaq Global Market listing.
DIH Holding US, Inc. reports that Nasdaq has added multiple listing deficiencies as bases for potential delisting of its Class A common stock. The company previously failed to meet the $1.00 bid price requirement by the September 8, 2025 compliance date, and on September 12, 2025 Nasdaq staff notified DIH that this shortfall is an additional basis for delisting. DIH clarifies that the same notice also cited its failure to file its Form 10-Q for the period ended June 30, 2025 and Form 10-K for the year ended March 31, 2025 under the Nasdaq Reports Rule.
The company has requested a hearing before a Nasdaq Hearing Panel, which has stayed suspension of trading for 15 days while DIH seeks an additional stay. At the hearing, the company plans to present a plan to regain compliance with the market value of listed securities rule (MVLS Rule), the bid price rule, and the reports rule, and may receive up to 180 days from the delisting determination for MVLS and bid price issues and up to 360 days from the initial filing delinquency to cure its reporting delays. DIH notes there is no assurance the Panel will grant continued listing or sufficient time to regain compliance.
DIH HOLDING US, INC. reported that a shareholder proposal related to the "Original Debentures Securities Purchase Agreement" was presented and approved by the required majority. The filing shows multiple voting tallies with shares for, against and abstaining across recorded votes, including tallies of 20,749,300 for, 839,940 against and 1,918,276 abstentions in one recorded vote and alternative tallies of 20,752,726 for, 839,524 against and 1,915,266 abstentions in another. The document is signed by Jason Chen, Chief Executive Officer and Chairman.
DIH Holding US, Inc. reports that Nasdaq has identified additional bases to delist its securities. The company failed to regain compliance with Nasdaq’s minimum bid price requirement, as its Class A common stock traded below $1.00 for 30 consecutive business days and did not recover by the September 8, 2025 compliance date. Nasdaq has also cited the company’s failure to timely file its Form 10-Q for the period ended June 30, 2025 and Form 10-K for the year ended March 31, 2025, as well as non-compliance with the minimum $50,000,000 market value of listed securities threshold for the Nasdaq Global Market.
The company has requested a hearing before a Nasdaq Hearing Panel, which has stayed the suspension of trading for 15 days, and it is seeking an additional stay. At the hearing, the company plans to present a plan to regain compliance with all listing criteria and ask for more time, but there is no assurance the panel will grant continued listing or that compliance can be achieved within any extension granted.
DIH Holding US, Inc. reported that its Board of Directors appointed Dr. Barrett Mooney as a Class III director, effective September 2, 2025, with a term expiring at the 2026 Annual Meeting of Stockholders. Dr. Mooney brings experience leading complex and manufacturing-related businesses, including prior roles as Chief Executive Officer and Chairman of a NYSE-American listed company and co-founder of a software firm, and he currently serves as Chief Operating Officer of Green Theme Technologies and President of Henry James Advisor Services.
Following three recent additions to the Board, DIH updated its Board committee assignments, naming Dr. Mooney to the Audit, Nominating & Corporate Governance, and Strategy Committees, and appointing him Chair of the Strategy Committee. The company also stated there are no related-party transactions requiring disclosure under Item 404 of Regulation S-K and issued a press release on September 8, 2025 announcing his appointment.
DIH Holding US, Inc. reported that its Nasdaq Global Market listing is at risk after failing to meet market value and filing requirements. Nasdaq staff notified the company on September 2, 2025 that its securities are subject to delisting because the company did not regain compliance with the $50,000,000 market value of listed securities requirement by the September 1, 2025 deadline.
The company also remains out of compliance for not timely filing its Form 10-K for the year ended March 31, 2025 and its Form 10-Q for the quarter ended June 30, 2025. DIH plans to request a hearing before a Nasdaq Hearing Panel, which will temporarily stay any suspension for 15 days from the request date, and will seek an additional stay and more time to meet all listing criteria.
The Panel may grant up to 180 days from the delisting determination to fix the market value issue and up to 360 days from the initial filing delinquency to cure the reporting failures, but the company cautions there is no assurance it will secure continued listing or regain compliance in time.
DIH Holding US, Inc. reported that on August 26, 2025 it received a notice from Nasdaq stating the company is not in compliance with Nasdaq Listing Rule 5250(c)(1) because it has not yet filed its Form 10-K for the year ended March 31, 2025 and its Form 10-Q for the period ended June 30, 2025. The company has until September 29, 2025 to submit a plan to regain compliance, and if Nasdaq accepts that plan, the company may have until January 12, 2026 to become current in its SEC filings.
The company says it is working with its auditors and advisors and intends to file the delinquent reports as soon as possible. The notice does not immediately affect the listing or trading of DIH Holding US, Inc.’s common stock or warrants on Nasdaq.
DIH Holding US sold an aggregate of $2,222,222 in principal of 8% Original Issue Discount senior secured convertible debentures, issued with a $222,222 original issue discount, resulting in approximately $2.0 million of gross proceeds and roughly $1.9 million net after offering expenses. The Debentures are initially convertible at $0.25 per share, subject to adjustment, and conversion is limited so a holder cannot exceed 9.99% beneficial ownership.
The Debentures mature in September 2026, carry an 8% annual rate with no interest payable during the first year and monthly redemptions beginning October 1, 2025 of $170,940.17 (payable in cash or, subject to formula limits, shares). Purchasers also received warrants for an aggregate of 8,888,888 shares at a $0.25 exercise price (five‑year term, exercisable February 1, 2026). The transaction includes registration rights covering the registrable securities and a voting agreement from Jason Chen in favor of required shareholder approvals.
DIH Holding US, Inc. (Nasdaq: DHAI) filed a Form 8-K reporting the 4 Aug 2025 appointment of Scott R. Burell to its Board of Directors. Burell, an experienced healthcare CFO now serving at AIVITA Biomedical and formerly at CombiMatrix during its sale to Invitae, joins as a Class III director with a term expiring at the 2026 annual meeting. He will also sit on the Audit, Compensation, and Nominating & Corporate Governance Committees, adding finance and transaction expertise to these key oversight bodies. The company noted no related-party transactions under Item 404 and did not disclose new compensatory arrangements. An accompanying press release (Ex. 99.1) dated 7 Aug 2025 announces the move. No other operational or financial updates were included.